In patients who initiated dialysis, the use of erythropoietin-stimulating agents significantly improved nerve conduction [30], and in pediatric patients with iron deficiency anemia, peripheral neuropathy was observed to reverse after iron treatment [31]. The gene discussed is EPO; the disease is Iron deficiency anemia.